Skip to main content

RDY 572 (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release 180 mg / 240 mg)

Pill with imprint RDY 572 is White, Capsule-shape and has been identified as Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release 180 mg / 240 mg. It is supplied by Dr. Reddy’s Laboratories Limited.

Fexofenadine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 180 mg / 240 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 572

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release

Imprint
RDY 572
Strength
180 mg / 240 mg
Color
White
Size
21.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Limited
National Drug Code (NDC)
55111-0572 (Discontinued)
Inactive Ingredients
acetyltributyl citrate, croscarmellose sodium, silicon dioxide, ethylcellulose, copovidone, hypromelloses, microcrystalline cellulose, polyethylene glycol, sodium stearyl fumarate, magnesium silicate, titanium dioxide, hydrogenated cottonseed oil

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.